A DC's Legends of Tomorrow episode confirmed that Curtis Knox, a villain on Smallville, is actually Vandal Savage.

Dr. Patrick Wen discussed with CURE how Modeyso treats diffuse midline glioma, and what unmet needs remain for patients now that the therapy is available. The U.S. Food and Drug Administration (FDA) ...

Andrew Ross is a teacher at Maumee Valley Country Day School. Ross runs in honor of his grandmother who survived breast cancer, and anyone impacted by the disease. Dolly Parton breaks silence on ...

Getting the treatment into the brain requires a complex surgery, during which doctors use MRI to guide tiny catheters into the correct spots in the organ. The treatment is given in one dose, so only ...

Some people embrace their baldness, but others are hoping for a cure. A team of researchers thinks the latter might soon be in reach. The researchers at the San Carlos Clinical Hospital in Madrid ...

The FDA has approved leucovorin, a folic acid form, potentially aiding in treating autism symptoms. Formerly manufactured by GSK as Wellcovorin, it was withdrawn from the market earlier. Studies ...

Fox's Murder in a Small Town allows Kristin Kreuk to work with a multitude of guest stars — but she's specifically holding out hope that her former Smallville love interest Tom Welling will make an ...

A gamer seeking financial support for cancer treatment lost $32,000 after downloading from Steam a verified game named BlockBlasters that drained his cryptocurrency wallet. BlockBlasters is a 2D ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Kreuk revealed she has been “really trying” to get Welling, 48, on the show, adding, “Because I ...

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...

Leucovorin brings hope as the first potential autism treatment, but with RFK Jr. weighing whether to fast-track approval, scientists worry about trust. When Nathaniel Schumann entered the clinical ...